Prevalence of Vitiligo Among Adults in the United States.
Saved in:
| Title: | Prevalence of Vitiligo Among Adults in the United States. |
|---|---|
| Authors: | Gandhi K; Patient & Health Impact, Pfizer, Collegeville, Pennsylvania., Ezzedine K; Department of Dermatology, Hôpital Henri-Mondor, Créteil, France., Anastassopoulos KP; Market Access Consulting, Labcorp Drug Development, Gaithersburg, Maryland., Patel R; Market Access Consulting, Labcorp Drug Development, Gaithersburg, Maryland., Sikirica V; Patient & Health Impact, Pfizer, Collegeville, Pennsylvania., Daniel SR; Market Access Consulting, Labcorp Drug Development, Gaithersburg, Maryland., Napatalung L; Medical Affairs, Pfizer, New York, New York., Yamaguchi Y; Inflammation & Immunology Research Unit, Pfizer, Collegeville, Pennsylvania., Baik R; Market Access Consulting, Labcorp Drug Development, Gaithersburg, Maryland., Pandya AG; Department of Dermatology, Palo Alto Foundation Medical Group, Sunnyvale, California.; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas. |
| Source: | JAMA dermatology [JAMA Dermatol] 2022 Jan 01; Vol. 158 (1), pp. 43-50. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
